AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Highlights of ASH 2022: CAR-T Therapy for Myeloma Patients
This chapter discusses the exciting highlights from the ASH 2022 conference, focusing on CAR-T therapy in myeloma patients. It covers challenges in CAR-T manufacturing slot access, prioritizing patients, studies on high-risk and early relapse patients, depth of response, imid combinations with CAR-T, and the impact of prior ADC or bi-specific treatments on response and progression-free survival.